AltruBio
繁
About us
Our Story
Our Leadership
Science
Our Science
Therapeutic Platforms
Our Product
ALTB-168
ALTB-268
Publications
News
Press Release
Media Coverage
Join us
Patients
Contact us
Current Trials
Front Line aGvHD
back
Front Line aGvHD
AbGn-168H
Neihulizumab
Trial
Therapeutics
AbGn-168H
Trial Number
NCT04144036
Disease Population
Trial Center
top
